SCHEMBL5506752

SCHEMBL5506752

CC(C(=O)NCCCN1CCC(c2cccc(NC(=O)C3CC3)c2)CC1)c1ccc(Cl)cc1

nearest known ligand 0.73

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 3/20 0.59
ACKR3 P25106 1/20 0.53
MCHR1 Q99705 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5507386 0.91 DRD2 (0.66) DRD2MCHR1
SCHEMBL5513966 0.91 ADRA1D (0.58) DRD2MCHR1
SCHEMBL5513891 0.91 DRD2 (0.71) DRD2MCHR1
SCHEMBL5513780 0.88 DRD2 (0.60) DRD2MCHR1
SCHEMBL5517533 0.84 DRD2 (0.71) DRD2MCHR1
SCHEMBL5511233 0.84 ADRA1D (0.72)
SCHEMBL5512821 0.84 ADRA1D (0.60) DRD2MCHR1
SCHEMBL5888057 0.83 DRD2 (0.67) DRD2MCHR1
SCHEMBL5888068 0.83 ADRA1D (0.64) MCHR1
SCHEMBL5522182 0.83 DRD2 (0.55) DRD2ACKR3MCHR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7199135-B2 Substituted alkyl amido piperidines H. LUNDBECK A/S (DK) 2007-04-03 US disclosed
US-7199135-B2 Substituted alkyl amido piperidines H. LUNDBECK A/S (DK) 2007-04-03 US disclosed
US-7199135-B2 Substituted alkyl amido piperidines H. LUNDBECK A/S (DK) 2007-04-03 US disclosed
US-7105544-B2 Substituted alkyl amido piperidines SYNAPTIC PHARMACEUTICAL CORPORATION (US) 2006-09-12 US disclosed
US-20060084649-A9 Substituted alkyl amido piperidines SYNAPTIC PHARMACEUTICAL CORPORATION (US) 2006-04-20 US disclosed
US-20060041139-A9 SUBSTITUTED ALKYL AMIDO PIPERIDINES H. LUNDBECK A/S (DK) 2006-02-23 US disclosed
US-20040186103-A1 Substituted alkyl amido piperidines SYNAPTIC PHARMACEUTICAL CORPORATION 2004-09-23 US disclosed
US-20040073036-A1 Substituted alkyl amido piperidines SYNAPTIC PHARMACEUTICAL CORPORATION 2004-04-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040073036-A1 Substituted alkyl amido piperidines MCHR1, MCHR2, MC1R DRD2 74/4885ACKR3 176/4885MCHR1 1/4885
US-20060084649-A9 Substituted alkyl amido piperidines MCHR1, MCHR2, MC1R DRD2 74/4885ACKR3 176/4885MCHR1 1/4885
US-20060041139-A9 SUBSTITUTED ALKYL AMIDO PIPERIDINES MCHR1, MCHR2, MC1R DRD2 74/4885ACKR3 176/4885MCHR1 1/4885
US-20040186103-A1 Substituted alkyl amido piperidines MCHR1, MCHR2, MC1R DRD2 74/4885ACKR3 176/4885MCHR1 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.